Sean Lavin

BTIG Says Buy The Dip In Medtronic

BTIG Turns Neutral On TransEnterix, Says Stock Rally Unsupported By Fundamentals

Tactile Systems' Valuation Is 'Getting Stretched,' BTIG Says In Downgrade

BTIG Turns Neutral On TransEnterix, Says Stock Rally Unsupported By Fundamentals

Tactile Systems' Valuation Is 'Getting Stretched,' BTIG Says In Downgrade

BTIG Expects 55% Upside In Exact Sciences

Insulet Downgraded Despite Expectations For Strong Performance

BTIG Expects 55% Upside In Exact Sciences

Insulet Downgraded Despite Expectations For Strong Performance

Analyst On Endologix: No Sense In Downgrading Now

Insulet: 'Results Have Been Stellar But So Has The Share Reaction'

Sean Lavin Recent News

The MedTech Group: 2017 Top Picks And Catalysts

BTIG On Organovo: '3D Bioprinting Addresses Multiple Potential Markets With Large Opportunities'

Here's Every Sell-Side Rating Following iRhythm's IPO Quiet Period Expiration

Investors Can Find A Compelling Entry Point In NeoGenomics After Recent Weakness

BTIG Moves To Neutral On DexCom, But Says Shares Are Not Overvalued

Tactile Systems Likely To Expand Sales And Marketing Effort Says BTIG

NeoGenomics Shares Nearing Full Valuation In BTIG's View

BTIG On Exact Sciences Leak: Final Task Force Stance Could Lead To Routine Reimbursement More Quickly

Medtronic's Spine Division Continues To Lag The Market

Intuitive Surgical Shares Downgraded To Neutral At BTIG

Promising Zika Research Fuels Cerus Stock Surge

Everyone's Talking About ROLARR Heading Into Intuitive Surgical Earnings: Here's What It Means

UPDATE: BTIG Research Initiates Coverage On Histogenics On NeoCart Potential

UPDATE: BTIG Research Downgrades Abiomed As FDA Overhang Is Gone

BTIG Likes What It Saw At Intuitive Surgical Conference

UPDATE: BTIG Upgrades Intuitive Surgical

BTIG Equity Research Bullish On Lombard Medical Inc

Analysts At BTIG Confident In Endologix Following Meeting With Top Executives

BTIG Research: Thoratec 'Drops A Bomb' In Its Second Quarter Results

BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share

UPDATE: BTIG Initiates Coverage On Masimo, Sees 31% Premium To Shares

UPDATE: BTIG Initiates Coverage On Intuitive Surgical

Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson